|
|
 |
Damavand, the highest Asian inactive volcano in the Alborz mountains, around 66 km in the northeastern Tehran, Iran (the highest elevation is 5,671 m) (Photo by M. H. Azizi MD, Winter 2015).
A winter view of Abali, around 57 km in the northeastern Tehran, Iran (Photo by M. H. Azizi MD, 2015).
|
|
|
|
|
|
|
|
|
The collection of articles appearing in the current book consists of manuscripts on the history of medicine in Iran, initially published from 1998 to 2014 in the “Archives of Iranian Medicine” (AIM). These articles are categorized into four separate parts, based on their subjects: Part 1) Ancient Times, Medieval Period, Part 2) Contemporary Medicine, Part 3) Outstanding Physicians and Part 4) Historical Background of Fatal Diseases in Iran. These 73 manuscripts have now been compiled in a 446 pages book for those who are interested in the history of Iranian medicine.more
Since the Archive of Iranian Medicine (AIM) journal presents as Open Access monthly, online periodical from May 2013, thus dear readers may refer to the journal website (www.aimjournal.ir) for free downloading of the published papers.
AIM Office
|
|
|
|
|
|
|
|
|
A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports®(JCR®) 2012 is 1.222.
|
|
|
|
|
Twelve-month Prevalence and Correlates of Psychiatric Disorders in Iran: The Iranian Mental Health Survey, 2011
1 |
|
Authors’ affiliations: 1Department of Psychiatry and Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, Iran. 2Department for Mental Health and Substance Use, Iranian Research Center for HIV/AIDS (IRCHA) and Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran. 3Mental Health Research Center, Tehran Institute of Psychiatry- Faculty of Behavioral Sciences and Mental Health, Iran University of Medical Sciences, Tehran, Iran. 4Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran. 5Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences and Tous Clinic, Tehran, Iran. 6Department for Mental Health and Substance Use, Iranian Research Center for HIV/AIDS (IRCHA) and Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran. 7Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
·Corresponding authors and reprints: Amin-Esmaeili Masoumeh MD MPH, Imam Khomeini Hospital, Keshavarz Blvd., Tehran, Iran.
Postal code: 14197-33141; Telefax: +98-21-66918899; +98-21-66947984; E-mail: m.aminesmaeeli@farabi.tums.ac.ir.
Hajebi Ahmad MD, Tehran Psychiatric Institute, Mansouri St., Nyayesh Ave., Sattarkhan Ave., Tehran, Iran; Tel: +98-21-66506862; E-mail: hajebi.a@iums.ac.ir
Accepted for publication: 14 January 2015
|
Download PDF Fulltext
|
|
Authors:
Vandad Sharifi1, *Masoumeh Amin-Esmaeili2, *Ahmad Hajebi3, Abbas Motevalian4, Reza Radgoodarzi5, Mitra Hefazi6, Afarin Rahimi-Movaghar7,
|
|
|
|
Keywords:
Epidemiology, Iran, Mental Health Survey, psychiatric disorders, prevalence
|
|
IMPORTANCE: No national information is available on the epidemiology of psychiatric disorders in Iran for the last decade.
OBJECTIVES: To estimate the 12-month prevalence of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) psychiatric disorders in Iranian population, and to investigate the severity and correlates of psychiatric disorders.
Design, setting and participants: The Iranian Mental Health Survey (IranMHS) was a nationally representative face-to-face household survey with a multistage, cluster sampling design that was carried out in 2011. A total of 7886 community dwelling residents aged 15–64 were recruited.
Main outcome measures: 12-month diagnoses of DSM-IV psychiatric disorders including mood, anxiety, and substance use disorders were assessed using a validated Persian translation of the Composite International Diagnostic Interview (CIDI; version 2.1). The Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I) was administered by a psychiatrist on subjects screened positive for the presence of a psychotic disorder. The severity of psychiatric disorders was determined using criteria that included markers for disability, particular diagnoses and suicide attempts.
RESULTS: The response rate was 86.2%. The 12-month weighted prevalence of “any psychiatric disorder” was 23.6% [95% confidence interval (CI): 22.4–24.8] with 26.5% of women and 20.8% of men having one or more psychiatric disorders. The most common category of psychiatric disorders was any anxiety disorder (15.6%) and the most prevalent particular disorder was major depressive disorder (12.7%), followed by generalized anxiety disorder (5.2%) and obsessive-compulsive disorder (5.1%). A 12-month psychotic disorder was observed in 0.5% of the population (95% CI: 0.33–0.66). Almost two-thirds (63.8%) of individuals with a mental disorder had moderate or serious illness. Unemployment, being widowed/divorced and urban living were associated with a greater likelihood of 12-month disorders; while, higher socioeconomic status and having a university degree were associated with a lower likelihood.
CONCLUSION: The high prevalence of psychiatric disorders, particularly major depression, merits further attention in the country’s mental health policy and program planning.
|
|
|
|
ISSN:1029-2977
Article type:Original
|
|
| |
|
|